SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19
PerkinElmer
JUNE 3, 2022
The second virtual screen focused on optimization of a hit from a previous crystallographic fragment screen. Fragment-to-lead optimization was guided by searches in a library of millions of compounds combined with docking screens to select the best candidate. 2021;374(6575):1586-1593. Clinicaltrials.gov.
Let's personalize your content